Dietary quality indices and biochemical parameters among patients with non alcoholic fatty liver disease (NAFLD)

Hepatitis Monthly

Volumn 13, Issue 7, 2013, Pages

  Hashemi Kani, Ali ^a,b   Alavian, Seyed Moayed ^c   Esmaillzadeh, Ahmad ^a,b   Adibi, Peyman ^b   Azadbakht, Leila ^a,b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Biochemical Processes; Diet Therapy; Healthy People Programs; Non alcoholic Fatty Liver Disease

Indexed keywords

ANTIOXIDANT; LOW DENSITY LIPOPROTEIN;

ADULT; AGE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; BODY WEIGHT; CASE CONTROL STUDY; CONTROLLED STUDY; DEMOGRAPHY; DIETARY DIVERSITY SCORE; DIETARY ENERGY DENSITY; DIETARY INTAKE; FEMALE; FOOD GUIDE PYRAMID; HEALTHY EATING INDEX; HUMAN; HYPERTRANSAMINASEMIA; IRAN; MAJOR CLINICAL STUDY; MALE; MEAN ADEQUACY RATIO; MEDICAL HISTORY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NONALCOHOLIC FATTY LIVER; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84881251512     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.10943     Document Type: Article

References (59)

1. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37(4):917-23.
2. Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis. 2007;191(2):235-40.
3. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 2005;42(1):44-52.
4. Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? J Gastroenterol Hepatol. 2007;22(6):794-800.
5. Naghavi M. Etiology of death in 18 provinces of Iran in year 2001. Tehran: Ministry of Health and Medical Education IR Iran. 2003;21.
6. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 1990;12(5):1106-10.
7. Alavian SM, Mohammad-Alizadeh AH, Esna-Ashari F, Ardalan G, Hajarizadeh B. Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures. Liver Int. 2009;29(2):159-63.
8. Jamali R, Khonsari M, Merat S, Khoshnia M, Jafari E, Bahram Kalhori A, et al. Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes. World J Gastroenterol. 2008;14(18):2867-71.
9. Bahrami H, Daryani NE, Mirmomen S, Kamangar F, Haghpanah B, Djalili M. Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients. BMC Gastroenterol. 2003;3:27.
10. Carvalhana S, Machado MV, Cortez-Pinto H. Improving dietary patterns in patients with nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care. 2012;15(5):468-73.
11. Santomauro M, Paoli-Valeri M, Fernandez M, Camacho N, Molina Z, Cicchetti R, et al. [Non-alcoholic fatty liver disease and its association with clinical and biochemical variables in obese children and adolescents: effect of a one-year intervention on lifestyle]. Endocrinol Nutr. 2012;59(6):346-53.
12. Ahmed MH, Barakat S, Almobarak AO. Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists? J Obes. 2012;2012:483135.
13. Agius L. High-carbohydrate diets induce hepatic insulin resistance to protect the liver from substrate overload. Biochem Pharmacol. 2013;85(3):306-12.
14. Colak Y, Tuncer I, Senates E, Ozturk O, Doganay L, Yilmaz Y. Nonalcoholic fatty liver disease: a nutritional approach. Metab Syndr Relat Disord. 2012;10(3):161-6.
15. D'Souza A M, Beaudry JL, Szigiato AA, Trumble SJ, Snook LA, Bonen A, et al. Consumption of a high-fat diet rapidly exacerbates the development of fatty liver disease that occurs with chronically elevated glucocorticoids. Am J Physiol Gastrointest Liver Physiol. 2012;302(8):G850-63.
16. Zivkovic AM, German JB, Sanyal AJ. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr. 2007;86(2):285-300.
17. Machado RM, Stefano JT, Oliveira CP, Mello ES, Ferreira FD, Nunes VS, et al. Intake of trans fatty acids causes nonalcoholic steatohepatitis and reduces adipose tissue fat content. J Nutr. 2010;140(6):1127-32.
18. Shi L, Liu ZW, Li Y, Gong C, Zhang H, Song LJ, et al. The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu. Biomed Environ Sci. 2012;25(4):383-91.
19. Papandreou D, Karabouta Z, Pantoleon A, Rousso I. Investigation of anthropometric, biochemical and dietary parameters of obese children with and without non-alcoholic fatty liver disease. Appetite. 2012;59(3):939-44.
20. Papandreou D, Karabouta Z, Rousso I. Are dietary cholesterol intake and serum cholesterol levels related to nonalcoholic Fatty liver disease in obese children? Cholesterol. 2012;2012:572820.
21. Goletzke J, Buyken AE, Gopinath B, Rochtchina E, Barclay AW, Cheng G, et al. Carbohydrate quality is not associated with liver enzyme activity and plasma TAG and HDL concentrations over 5 years in an older population. Br J Nutr. 2013:1-8.
22. Esmaillzadeh A, Azadbakht L. Major dietary patterns in relation to general obesity and central adiposity among Iranian women. J Nutr. 2008;138(2):358-63.
23. Azadbakht L, Esmaillzadeh A. Dietary and non-dietary determinants of central adiposity among Tehrani women. Public Health Nutr. 2008;11(5):528-34.
24. Azadbakht L, Mirmiran P, Shiva N, Azizi F. General obesity and central adiposity in a representative sample of Tehranian adults: prevalence and determinants. Int J Vitam Nutr Res. 2005;75(4):297-304.
25. Senates E, Colak Y, Yesil A, Coskunpinar E, Sahin O, Kahraman OT, et al. Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores. Minerva Med. 2012;103(5):369-76.
26. McPherson S, Anstee QM, Henderson E, Day CP, Burt AD. Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels? Eur J Gastroenterol Hepatol. 2013;25(6):652-8.
27. Willett W. Nutritional epidemiology. 1998.
28. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii.
29. Aronne LJ. Classification of obesity and assessment of obesityrelated health risks. Obes Res. 2002;10 Suppl 2:105S-115S.
30. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi F. Dietary diversity score and cardiovascular risk factors in Tehranian adults. Public Health Nutr. 2006;9(6):728-36.
31. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F. Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes Care. 2005;28(12):2823-31.
32. Kant AK, Block G, Schatzkin A, Ziegler RG, Nestle M. Dietary diversity in the US population, NHANES II, 1976-1980. J Am Diet Assoc. 1991;91(12):1526-31.
33. Kant AK, Schatzkin A, Ziegler RG. Dietary diversity and subsequent cause-specific mortality in the NHANES I epidemiologic follow-up study. J Am Coll Nutr. 1995;14(3):233-8.
34. United States. Dept. of Agriculture. Human Nutrition Information Service. USDA's food guide pyramid. 1992.
35. Kennedy ET, Ohls J, Carlson S, Fleming K. The Healthy Eating Index: design and applications. J Am Diet Assoc. 1995;95(10):1103-8.
36. Mahan LK, Escott-Stump S. Krause's Food and Nutrition Therapy. 2008.
37. Mirmiran P, Azadbakht L, Esmaillzadeh A, Azizi F. Dietary diversity score in adolescents-a good indicator of the nutritional adequacy of diets: Tehran lipid and glucose study. Asia Pac J Clin Nutr. 2004;13(1):56-60.
38. Ledikwe JH, Blanck HM, Khan LK, Serdula MK, Seymour JD, Tohill BC, et al. Dietary energy density determined by eight calculation methods in a nationally representative United States population. J Nutr. 2005;135(2):273-8.
39. Maillot M, Darmon N, Vieux F, Drewnowski A. Low energy density and high nutritional quality are each associated with higher diet costs in French adults. Am J Clin Nutr. 2007;86(3):690-6.
40. Schroder H, Covas M, Elosua R, Mora J, Marrugat J. Diet quality and lifestyle associated with free selected low-energy density diets in a representative Spanish population. Eur J Clin Nutr. 2008;62(10):1194-200.
41. Stern L, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, et al. The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial. Ann Intern Med. 2004;140(10):778-85.
42. Azadbakht L, Mirmiran P, Hosseini F, Azizi F. Diet quality status of most Tehranian adults needs improvement. Asia Pac J Clin Nutr. 2005;14(2):163-8.
43. Mirmiran P, Azadbakht L, Azizi F. Dietary quality-adherence to the dietary guidelines in Tehranian adolescents: Tehran Lipid and Glucose Study. Int J Vitam Nutr Res. 2005;75(3):195-200.
44. Azadbakht L, Esmaillzadeh A. Dietary energy density is favorably associated with dietary diversity score among female university students in Isfahan. Nutrition. 2012;28(10):991-5.
45. Mirmiran P, Azadbakht L, Azizi F. Dietary diversity within food groups: an indicator of specific nutrient adequacy in Tehranian women. J Am Coll Nutr. 2006;25(4):354-61.
46. Azadbakht L, Haghighatdoost F, Esmaillzadeh A. Dietary energy density is inversely associated with the diet quality indices among Iranian young adults. J Nutr Sci Vitaminol (Tokyo). 2012;58(1):29-35.
47. Bortolotti M, Kreis R, Debard C, Cariou B, Faeh D, Chetiveaux M, et al. High protein intake reduces intrahepatocellular lipid deposition in humans. Am J Clin Nutr. 2009;90(4):1002-10.
48. Lacroix M, Gaudichon C, Martin A, Morens C, Mathe V, Tome D, et al. A long-term high-protein diet markedly reduces adipose tissue without major side effects in Wistar male rats. Am J Physiol Regul Integr Comp Physiol. 2004;287(4):R934-42.
49. Schwarz J, Tome D, Baars A, Hooiveld GJ, Muller M. Dietary protein affects gene expression and prevents lipid accumulation in the liver in mice. PLoS One. 2012;7(10).
50. Shertzer HG, Woods SE, Krishan M, Genter MB, Pearson KJ. Dietary whey protein lowers the risk for metabolic disease in mice fed a high-fat diet. J Nutr. 2011;141(4):582-7.
51. Lockwood DH, Amatruda JM, Moxley RT, Pozefsky T, Boitnott JK. Effect of oral amino acid supplementation on liver disease after jejunoileal bypass for morbid obesity. Am J Clin Nutr. 1977;30(1):58-63.
52. Meghelli-Bouchenak M, Belleville J, Boquillon M. Hepatic steatosis and serum very low density lipoproteins during two types of protein malnutrition followed by balanced refeeding. Nutrition. 1989;5(5):321-9.
53. Uebanso T, Taketani Y, Fukaya M, Sato K, Takei Y, Sato T, et al. Hypocaloric high-protein diet improves fatty liver and hypertriglyceridemia in sucrose-fed obese rats via two pathways. Am J Physiol Endocrinol Metab. 2009;297(1):E76-84.
54. Caporaso N, Morisco F, Camera S, Graziani G, Donnarumma L, Ritieni A. Dietary approach in the prevention and treatment of NAFLD. Front Biosci. 2012;17:2259-68.
55. Oliveira CP, Gayotto LC, Tatai C, Della Nina BI, Lima ES, Abdalla DS, et al. Vitamin C and vitamin E in prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in choline deficient diet fed rats. Nutr J. 2003;2:9.
56. Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G, et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2007;17(7):517-24.
57. Thomas AP, Dunn TN, Drayton JB, Oort PJ, Adams SH. A dairybased high calcium diet improves glucose homeostasis and reduces steatosis in the context of preexisting obesity. Obesity (Silver Spring). 2013;21(3):E229-35.
58. Zelber-Sagi S, Ratziu V, Oren R. Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol. 2011;17(29):3377-89.
59. Razavizade M, Jamali R, Arj A, Talari H. Serum parameters predict the severity of ultrasonographic findings in non-alcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int. 2012;11(5):513-20.